Suppr超能文献

新型同手性双吡咯烷作为潜在DNA交联抗肿瘤药物的合成

Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.

作者信息

Anderson F M, O'Hare C C, Hartley J A, Robins D J

机构信息

Department of Chemistry, University of Glasgow, UK.

出版信息

Anticancer Drug Des. 2000 Apr;15(2):119-26.

Abstract

We are seeking to develop more effective bifunctional alkylating agents as antitumour agents. We previously synthesized conformationally restricted nitrogen mustards containing one piperidine ring, then bispiperidine derivatives were designed and prepared with varying lengths of carbon chain between the two rings and structure-activity relationships in these systems were studied. A bispiperidine with the shortest bridge of two carbon atoms was the most reactive bifunctional alkylating agent. In order to extend this work and investigate the effects of a change in the size of the heterocyclic systems, new bispyrrolidine salts 17-23 with chloromethyl groups at the 2-positions and a bridge between the two nitrogen atoms of 2-8 carbon atoms were synthesized from L-proline so that only the LL-enantiomers were produced. The free bases were designed to be bifunctional alkylating agents via aziridinium ion formation with different distances between the two alkylating sites. All of the bispyrrolidines were efficient cross-linkers of naked DNA apart from those with three-carbon (18) and four-carbon (19) bridges, in contrast to the results with the bispiperidines. A piperazine derivative 24 with two potential alkylating sites was also shown to be an efficient cross-linker, as was an alicyclic compound 25 with six carbon atoms between the two alkylating sites. Compounds 26 and 30 with an extra carbon atom between the nitrogen and the leaving group were not cross-linkers, as expected if aziridinium ion formation is crucial for cross-linking ability. The preformed aziridine 27 with a further alkylating site was an efficient cross-linker. Compounds 28-29 with only one potential alkylating centre were not cross-linkers of DNA. None of the compounds, however, produced significant cytotoxicity in human tumour cells in vitro.

摘要

我们正在寻求开发更有效的双功能烷基化剂作为抗肿瘤药物。我们之前合成了含有一个哌啶环的构象受限氮芥,然后设计并制备了双哌啶衍生物,两个环之间具有不同长度的碳链,并研究了这些体系中的构效关系。具有两个碳原子最短桥连的双哌啶是反应性最强的双功能烷基化剂。为了扩展这项工作并研究杂环体系大小变化的影响,从L-脯氨酸合成了新的2-位带有氯甲基且两个氮原子之间桥连为2-8个碳原子的双吡咯烷盐17-23,从而只产生LL-对映体。游离碱被设计为通过形成氮丙啶离子成为双功能烷基化剂,两个烷基化位点之间具有不同距离。与双哌啶的结果相反,除了具有三碳(18)和四碳(19)桥连的双吡咯烷外,所有双吡咯烷都是裸露DNA的有效交联剂。具有两个潜在烷基化位点的哌嗪衍生物24也被证明是一种有效的交联剂,在两个烷基化位点之间具有六个碳原子的脂环族化合物25也是如此。在氮原子和离去基团之间带有一个额外碳原子的化合物26和30不是交联剂,如果氮丙啶离子的形成对交联能力至关重要,这是预期的结果。具有另一个烷基化位点的预制氮丙啶27是一种有效的交联剂。仅具有一个潜在烷基化中心的化合物28-29不是DNA的交联剂。然而,这些化合物在体外对人肿瘤细胞均未产生显著的细胞毒性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验